PNEUMONIA, BACTERIAL
Clinical trials for PNEUMONIA, BACTERIAL explained in plain language.
Never miss a new study
Get alerted when new PNEUMONIA, BACTERIAL trials appear
Sign up with your email to follow new studies for PNEUMONIA, BACTERIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pneumonia vaccine booster for toddlers enters safety trial
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage study tests a new pneumococcal vaccine booster in 45 toddlers aged 12-15 months who already received their routine pneumonia shots. The goal is to check for side effects like tenderness, fever, and sleepiness. The study compares the new vaccine to an existing one…
Matched conditions: PNEUMONIA, BACTERIAL
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Aug 01, 2026 00:00 UTC
-
Inhaled antibiotics aim to beat pneumonia in ECMO patients
Disease control Recruiting nowThis study investigates whether inhaling the antibiotic amikacin can better treat pneumonia caused by gram-negative bacteria in patients on veno-arterial ECMO (a heart-lung bypass machine). Standard antibiotics often fail in these patients, possibly because the bypass reduces blo…
Matched conditions: PNEUMONIA, BACTERIAL
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Virus cocktail targets superbug pneumonia in first human test
Disease control Recruiting nowThis early-stage trial tests MP101, a mix of two viruses that attack bacteria (phages), in 18 adults with Pseudomonas aeruginosa pneumonia. Participants receive a single dose of MP101 or a placebo alongside standard antibiotics. The main goal is to check safety and how the body h…
Matched conditions: PNEUMONIA, BACTERIAL
Phase: PHASE1 • Sponsor: MicrobiotiX Co., Ltd • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Which works better: one antibiotic or two for this superbug?
Knowledge-focused Recruiting nowThis study looks at 790 adults with S. maltophilia infections, a hard-to-treat bacteria. Researchers will compare patients who got one antibiotic versus those who got a combination, to see which group has fewer deaths within 30 days. The goal is to find the best treatment approac…
Matched conditions: PNEUMONIA, BACTERIAL
Sponsor: Instituto de Investigación Sanitaria Gregorio Marañón • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC